Envestnet Asset Management
DCPH

Envestnet Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Envestnet Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,832
Closed -$375K – 4326
2024
Q1 		$375K Buy
23,832
+3,025
+15% +$46.6K ﹤0.01% 3607
2023
Q4 		$336K Buy
20,807
+192
+0.9% +$2.45K ﹤0.01% 3553
2023
Q3 		$262K Buy
20,615
+8,650
+72% +$119K ﹤0.01% 3612
2023
Q2 		$168K Sell
11,965
-664
-5% -$9.5K ﹤0.01% 3747
2023
Q1 		$195K Buy
+12,629
New +$211K ﹤0.01% 3662

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Envestnet Asset Management's DCPH Position: Q2 2024 in Review

Envestnet Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 23,832 shares — an estimated $375K sold.

Envestnet Asset Management first reported a position in DCPH in Q1 2023 and held it in 5 quarters. The position peaked at $375K in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Envestnet Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 23,832 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $375K.
  • Envestnet Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • Envestnet Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $375K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Envestnet Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.